Knock down of the toxic BH3 domain protein BID, which is downstream of CD95, FADD and pro-caspase 8, significantly reduced the ability of regorafenib alone or in combination with aramchol to cause autophagosome and autolysosome formation and to kill tumor cells. The gene discussed is CASP8; the disease is neoplasm.